Triglyceride accumulation inhibitory effects of new chromone glycosides from Drynaria fortunei

Two new chromone glycosides, drynachromosides C (1) and D (2), along with five known chromones (3–7), were isolated from the rhizomes of Drynaria fortunei. The structures of the two new compounds were elucidated on the basis of physico-chemical property and spectroscopic data. Triglyceride (TG) accumulation inhibitory effects of the obtained chromones on 3T3-L1 cells were investigated. The results showed that 1, 2 and 5 exhibited inhibitory activity on TG accumulation. Effects of compounds 1 and 2 on mRNA expression of PPARγ, C/EBPα and aP2 in 3T3-L1 cells were also investigated.

[1]  Jung-Chun Liao,et al.  Protective effects of Drynaria fortunei against 6-hydroxydopamine-induced oxidative damage in B35 cells via the PI3K/AKT pathway. , 2014, Food & function.

[2]  Jing Dong,et al.  Comprehensive Chemical Analysis of the Rhizomes of Drynaria fortunei by Orthogonal Pre-Separation and Liquid Chromatography Mass Spectrometry , 2014, Planta Medica.

[3]  Yi Zhang,et al.  Triglyceride accumulation inhibitory effects of phenylpropanoid glycosides from Boschniakia rossica Fedtsch et Flerov. , 2013, Fitoterapia.

[4]  P. Leung,et al.  Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone , 2013, British Journal of Nutrition.

[5]  Lin Yang,et al.  Two new chromone glycosides from Drynaria fortunei. , 2013, Fitoterapia.

[6]  Yanming Xie,et al.  Population pharmacokinetics of naringin in total flavonoids of Drynaria Fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis , 2012, Chinese Journal of Integrative Medicine.

[7]  Mi Kyeong Lee,et al.  Anti-adipogenic chromone glycosides from Cnidium monnieri fruits in 3T3-L1 cells. , 2012, Bioorganic & medicinal chemistry letters.

[8]  X. Qiao,et al.  Flavan-3-ols from the rhizomes of Drynaria fortunei. , 2011, Phytochemistry.

[9]  Xinluan Wang,et al.  Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  Ning-bo Gong,et al.  A new chiratane type triterpenoid from the rhizomes of Drynaria fortunei. , 2010, Fitoterapia.

[11]  Ta-Liang Chen,et al.  Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. , 2010, Journal of ethnopharmacology.

[12]  L. Qin,et al.  Phenylpropanoid and flavonoids from osteoprotective fraction of Drynaria fortunei , 2010, Natural product research.

[13]  W. Lewis,et al.  Synthesis of the oxepinochromone natural products ptaeroxylin (desoxykarenin), ptaeroxylinol, and eranthin. , 2010, The Journal of organic chemistry.

[14]  T. Nohara,et al.  Chromone and flavonol glycosides from Delphinium hybridum cv. “Belladonna Casablanca” , 2007, Journal of Natural Medicines.

[15]  H. Waki,et al.  Endocrine functions of adipose tissue. , 2007, Annual review of pathology.

[16]  S. Farmer,et al.  Regulation of PPARγ activity during adipogenesis , 2005, International Journal of Obesity.

[17]  S. Farmer.  Regulation of PPARgamma activity during adipogenesis. , 2005, International journal of obesity.

[18]  B. Spiegelman,et al.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. , 2002, Genes & development.

[19]  J. Storch,et al.  Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. , 2000, Diabetes.

[20]  Elizabeth R. Smith,et al.  Adipocyte Metabolism in Adipocyte Fatty Acid Binding Protein Knockout ( aP 2 – / – ) Mice After S h o r t-Term High-Fat Feeding Functional Compensation by the Keritinocyte Fatty Acid Binding Protein , 2000 .

[21]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[22]  B. Spiegelman,et al.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.

[23]  O. MacDougald,et al.  The Role of C/EBP Genes in Adipocyte Differentiation* , 1998, The Journal of Biological Chemistry.

[24]  J. D. Connolly,et al.  Chromone glycosides from Schumanniophyton magnificum. , 1990, Phytochemistry.